{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:07:57Z","timestamp":1785424077691,"version":"3.56.0"},"reference-count":49,"publisher":"North Carolina Institute of Medicine","issue":"6","license":[{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"\n Background<\/jats:title>\n In this study, we aimed to examine postpartum health care utilization and identify gaps in care among a postpartum Medicaid population of patients diagnosed with opioid use disorder (OUD) during pregnancy.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n We queried North Carolina Medicaid medical and pharmacy claims to identify individuals with a live delivery and evidence of OUD during pregnancy from 2015 to 2019. We examined any evidence of postpartum health care utilization and evidence of medications for OUD (MOUD) during postpartum. We also determined the impact that 4 factors may have had on these outcomes: type of Medicaid coverage (Medicaid for Pregnant Women as compared to other types of Medicaid coverage), rurality, race, and the prenatal use of MOUD. Descriptive statistics, Kaplan-Meier curves with log-rank tests, and negative binomial regression were used.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Of the 6,186 individuals in the study, 84.5% were White, 29.6% lived in rural areas, and 35.0% had MPW coverage. Of the sample, 77.4% sought health care services during the postpartum period. In the multiple negative binomial regression model, individuals who were MPW beneficiaries, non-White, lived in rural areas, and had no evidence of prenatal MOUD all had significantly lower rates of postpartum health care utilization. Of the sample, 53.6% had evidence of MOUD utilization during the postpartum period. We found that patients with MPW continued MOUD at much lower rates compared to patients with other forms of Medicaid (86% versus 93% at 60 days; 57% versus 78% at 180 days, respectively).<\/jats:p>\n <\/jats:sec>\n \n Limitations<\/jats:title>\n Limitations to this analysis are inherent to administrative claims data, such as misclassification of outcomes and covariates, as well as loss to follow-up.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Significant gaps in health care use remain across type of Medicaid coverage, race, geographic setting, and prenatal care access.<\/jats:p>\n <\/jats:sec>","DOI":"10.18043\/001c.125106","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T12:47:18Z","timestamp":1731502038000},"source":"Crossref","is-referenced-by-count":0,"title":["Postpartum Access to Health Care and Opioid Use Treatment: An Evaluation of a Medicaid Population"],"prefix":"10.18043","volume":"85","author":[{"given":"Casey","family":"Tak","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03r0ha626","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Utah","department":["Department of Pharmacotherapy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bayla","family":"Ostrach","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05qwgg493","id-type":"ROR","asserted-by":"publisher"}],"name":"Boston University","department":["Chobanian & Avedisian School of Medicine"]},{"name":"Fruit of Labor Action Research & Technical Assistance, LLC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda","family":"Ramage","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/031vnay14","id-type":"ROR","asserted-by":"publisher"}],"name":"Mountain Area Health Education Center","department":["Department of Obstetrics and Gynecology"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7507","published-online":{"date-parts":[[2024,11,13]]},"reference":[{"issue":"3","key":"ref1","doi-asserted-by":"publisher","first-page":"e200538","DOI":"10.1001\/jamanetworkopen.2020.0538","article-title":"USPSTF\u2019s hepatitis C screening recommendation\u2014A necessary step to tackling an evolving epidemic","volume":"3","author":"E. S. Rosenberg","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"5","key":"ref2","doi-asserted-by":"publisher","first-page":"e205734","DOI":"10.1001\/jamanetworkopen.2020.5734","article-title":"Assessment of racial and ethnic disparities in the use of medication to treat opioid use disorder among pregnant women in Massachusetts","volume":"3","author":"D. M. Schiff","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"2","key":"ref3","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.jval.2020.08.2098","article-title":"Disparities in access to opioid treatment programs and office-based buprenorphine treatment across the rural-urban and area deprivation continua: A US nationwide small area analysis","volume":"24","author":"S. Amiri","year":"2021","journal-title":"Value Health"},{"key":"ref4","article-title":"The opioid epidemic and Medicaid\u2019s role in facilitating access to treatment","author":"K. Orgera","year":"2019","journal-title":"KFF"},{"issue":"1","key":"ref5","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12884-021-03596-w","article-title":"\u201cThe elephant in the room;\u201d a qualitative study of perinatal fears in opioid use disorder treatment in Southern Appalachia","volume":"21","author":"C. Leiner","year":"2021","journal-title":"BMC Pregnancy Childbirth"},{"key":"ref6","article-title":"Basic Medicaid eligibility","author":"North Carolina Department of Health and Human Services"},{"issue":"1","key":"ref7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.18043\/ncm.81.1.51","article-title":"Medicaid coverage for pregnant women: A pathway to healthy outcomes for moms and children","volume":"81","author":"W. Tucker","year":"2020","journal-title":"N C Med J"},{"issue":"4","key":"ref8","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1097\/adm.0000000000000491","article-title":"\u201cI didn\u2019t want to be on Suboxone at first...\u201d - Ambivalence in perinatal substance use treatment","volume":"13","author":"B. Ostrach","year":"2019","journal-title":"J Addict Med"},{"issue":"3","key":"ref9","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.drugalcdep.2008.12.007","article-title":"Predictors of injection drug use cessation and relapse in a prospective cohort of young injection drug users in San Francisco, CA (UFO Study)","volume":"101","author":"J. L. Evans","year":"2009","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"ref10","doi-asserted-by":"publisher","first-page":"e67405","DOI":"10.1371\/journal.pone.0067405","article-title":"Harnessing the Medicaid Analytic eXtract (MAX) to evaluate medications in pregnancy: Design considerations","volume":"8","author":"K. Palmsten","year":"2013","journal-title":"PloS One"},{"issue":"31","key":"ref11","doi-asserted-by":"publisher","first-page":"845","DOI":"10.15585\/mmwr.mm6731a1","article-title":"Opioid use disorder documented at delivery hospitalization - United States, 1999\u20132014","volume":"67","author":"S.C. Haight","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"ref12","doi-asserted-by":"publisher","first-page":"100179","DOI":"10.1016\/j.ajogmf.2020.100179","article-title":"Buprenorphine-naloxone use in pregnancy: A systematic review and metaanalysis","volume":"2","author":"H. M. Link","year":"2020","journal-title":"Am J Obstet Gynecol MFM"},{"key":"ref13","article-title":"RUCA Data","journal-title":"Rural Health Research Center"},{"issue":"5","key":"ref14","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1097\/AOG.0b013e3182a603bb","article-title":"Development of a comorbidity index for use in obstetric patients","volume":"122","author":"B. T. Bateman","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"1","key":"ref15","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/adm.0000000000000827","article-title":"Medication for addiction treatment and postpartum health care utilization among pregnant persons with opioid use disorder","volume":"16","author":"K. A. Ahrens","year":"2022","journal-title":"J Addict Med"},{"key":"ref16","article-title":"Key Substance Use and Mental Health Indicators in the United States: Results from the 2018 National Survey on Drug Use and Health","author":"Substance Abuse and Mental Health Services Administration (SAMHSA)","year":"2019"},{"issue":"Suppl 1","key":"ref17","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s10995-016-2043-8","article-title":"Healthcare utilization in the postpartum period among Illinois women with Medicaid paid claims for delivery, 2009\u20132010","volume":"20","author":"K. M. Rankin","year":"2016","journal-title":"Matern Child Health J"},{"key":"ref18","series-title":"Opioid-Use Disorders in Pregnancy: Management Guidelines for Improving Outcomes","first-page":"105","article-title":"Postpartum care for women with substance use disorders","author":"E. E. Krans","year":"2018"},{"issue":"1","key":"ref19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40352-015-0015-5","article-title":"Pregnant women and substance use: Fear, stigma, and barriers to care","volume":"3","author":"R. Stone","year":"2015","journal-title":"Health & Justice"},{"issue":"2","key":"ref20","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1215\/03616878-1966324","article-title":"Arrests of and forced interventions on pregnant women in the United States, 1973\u20132005: Implications for women\u2019s legal status and public health","volume":"38","author":"L. M. Paltrow","year":"2013","journal-title":"J Health Polit Policy Law"},{"issue":"3","key":"ref21","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1080\/08897077.2019.1573209","article-title":"The impact of Medicaid expansion on postpartum health care utilization among pregnant women with opioid use disorder","volume":"40","author":"B. P. Patton","year":"2019","journal-title":"Substance Abus"},{"issue":"2","key":"ref22","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1001\/jama.2020.24991","article-title":"Neonatal abstinence syndrome and maternal opioid-related diagnoses in the US, 2010\u20132017","volume":"325","author":"A. H. Hirai","year":"2021","journal-title":"JAMA"},{"issue":"2","key":"ref23","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1097\/aog.0000000000002734","article-title":"Fatal and nonfatal overdose among pregnant and postpartum women in Massachusetts","volume":"132","author":"D. M. Schiff","year":"2018"},{"issue":"9","key":"ref24","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1001\/jamapsychiatry.2019.0876","article-title":"Buprenorphine treatment divide by race\/ethnicity and payment","volume":"76","author":"P. A. Lagisetty","year":"2019","journal-title":"JAMA Psychiatry"},{"issue":"10","key":"ref25","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.2105\/AJPH.2020.305748","article-title":"Exploration of the STOP Act and opioid deaths in North Carolina, 2010\u20132018","volume":"110","author":"P. Hughes","year":"2020","journal-title":"Am J Public Health"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"209171","DOI":"10.1016\/j.josat.2023.209171","article-title":"Examining differences in opioid deaths by race in North Carolina following the STOP Act, 2010\u2013 2019","volume":"155","author":"P. M. Hughes","year":"2023","journal-title":"J Subst Use Addict Treat"},{"issue":"4","key":"ref27","doi-asserted-by":"publisher","first-page":"e203711","DOI":"10.1001\/jamanetworkopen.2020.3711","article-title":"Association of racial\/ethnic segregation with treatment capacity for opioid use disorder in counties in the United States","volume":"3","author":"W. C. Goedel","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"4","key":"ref28","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/1468-0009.00223","article-title":"Trust in physicians and medical institutions: What is it, can it be measured, and does it matter?","volume":"79","author":"M. A. Hall","year":"2001","journal-title":"Milbank Q"},{"issue":"3","key":"ref29","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1353\/hpu.2014.0115","article-title":"Trust in health care providers: Factors predicting trust among homeless veterans over time","volume":"25","author":"C. van den Berk-Clark","year":"2014","journal-title":"J Health Care Poor Underserved"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1097\/01.aids.0000363777.76129.b4","article-title":"Determinants of contraceptive choice among women with HIV","volume":"23 Suppl 1","author":"M. K. Whiteman","year":"2009","journal-title":"AIDS"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ypmed.2015.04.008","article-title":"Contraceptive use and method choice among women with opioid and other substance use disorders: A systematic review","volume":"80","author":"M. Terplan","year":"2015","journal-title":"Prev Med"},{"issue":"2","key":"ref32","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jsat.2010.08.011","article-title":"Unintended pregnancy in opioid-abusing women","volume":"40","author":"S. H. Heil","year":"2011","journal-title":"J Subst Abuse Treat"},{"key":"ref33","article-title":"Substance use, misuse, and use disorders during and following pregnancy, with an emphasis on opioids","author":"American Society of Addiction Medicine","year":"2017"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.drugalcdep.2017.12.023","article-title":"Postpartum contraceptive use and interpregnancy interval among women with opioid use disorder","volume":"185","author":"E. E. Krans","year":"2018","journal-title":"Drug Alcohol Depend"},{"issue":"19","key":"ref35","doi-asserted-by":"publisher","first-page":"575","DOI":"10.15585\/mmwr.mm6919a2","article-title":"Vital signs: Postpartum depressive symptoms and provider discussions about perinatal depression - United States, 2018","volume":"69","author":"B. L. Bauman","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref36","article-title":"Health check program guide","author":"North Carolina Medicaid","year":"2020"},{"key":"ref37","article-title":"Symptoms of depression among women","journal-title":"Centers for Disease Control and Prevention"},{"key":"ref38","article-title":"Antidepressant use among adults: United States, 2015\u20132018","author":"D. J. Brody","year":"2020","journal-title":"Centers for Disease Control"},{"issue":"4","key":"ref39","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1080\/00952990802122358","article-title":"Comparison of characteristics of opioid-using pregnant women in rural and urban settings","volume":"34","author":"S. H. Heil","year":"2008","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"3","key":"ref40","doi-asserted-by":"publisher","first-page":"157","DOI":"10.18043\/ncm.81.3.157","article-title":"A cohort comparison of differences between regional and Buncombe County patients of a comprehensive perinatal substance use disorders program in Western North Carolina","volume":"81","author":"S. L. Galvin","year":"2020","journal-title":"N C Med J"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.drugpo.2017.06.010","article-title":"Fentanyl in the US heroin supply: A rapidly changing risk environment","volume":"46","author":"D. Ciccarone","year":"2017","journal-title":"Int J Drug Policy"},{"issue":"2","key":"ref42","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/jrh.12546","article-title":"Exploration of the effects of rural obstetric unit closures on birth outcomes in North Carolina","volume":"37","author":"M. H. Sullivan","year":"2021","journal-title":"J Rural Health"},{"key":"ref43","article-title":"Improved Medicaid postpartum care benefits","author":"North Carolina Department of Health and Human Services","year":"2022"},{"issue":"1","key":"ref44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/ADM.0b013e318159d81a","article-title":"Management of addiction disorders in pregnancy","volume":"2","author":"G. D. Helmbrecht","year":"2008","journal-title":"J Addict Med"},{"issue":"9","key":"ref45","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1111\/add.15028","article-title":"Rooming-in and loss of child custody: Key factors in maternal overdose risk","volume":"115","author":"L. Mackay","year":"2020","journal-title":"Addiction"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"102977","DOI":"10.1016\/j.drugpo.2020.102977","article-title":"Overdose among mothers: The association between child removal and unintentional drug overdose in a longitudinal cohort of marginalised women in Canada","volume":"91","author":"M. Thumath","year":"2021","journal-title":"Int J Drug Policy"},{"issue":"5","key":"ref47","doi-asserted-by":"publisher","first-page":"e208","DOI":"10.1097\/AOG.0000000000002927","article-title":"ACOG committee opinion no. 757: Screening for perinatal depression","volume":"132","author":"American College of Obstetricians and Gynecologists","year":"2018","journal-title":"Obstet Gynecol"},{"key":"ref48","article-title":"Contraceptive use in the United States: Fact sheet","year":"2021","journal-title":"Guttmacher Institute"},{"issue":"39","key":"ref49","doi-asserted-by":"publisher","first-page":"833","DOI":"10.15585\/mmwr.mm6839a1","article-title":"National trends in hepatitis C infection by opioid use disorder status among pregnant women at delivery hospitalization - United States, 2000\u20132015","volume":"68","author":"J. Y. Ko","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["North Carolina Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ncmedicaljournal.com\/article\/125106-postpartum-access-to-health-care-and-opioid-use-treatment-an-evaluation-of-a-medicaid-population","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T20:11:39Z","timestamp":1780603899000},"score":1,"resource":{"primary":{"URL":"https:\/\/ncmedicaljournal.com\/article\/125106-postpartum-access-to-health-care-and-opioid-use-treatment-an-evaluation-of-a-medicaid-population"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,13]]},"references-count":49,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.18043\/001c.125106","relation":{},"ISSN":["2379-4313","0029-2559"],"issn-type":[{"value":"2379-4313","type":"electronic"},{"value":"0029-2559","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,13]]}}}